Status:
UNKNOWN
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18-75 years
Brief Summary
The aim of the study is to evaluate changes in autonomic nervous system following treatment with anticholinergic medication for OAB symptoms. Heart variability as a measure of the functioning of the ...
Detailed Description
30 women with clinical diagnosis of overactive bladder will be recruited for the study. An ECG strip for fifteen minutes at rest will be recorded through a 12-bit analog/digital data acquisition card ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of OAB
Exclusion
- 1\) stress urinary incontinence and voiding symptoms, 2) pregnancy, 3) pathological conditions that can interfere with the ANS, (e.g. coronary heart disease, heart failure, or other cardiac conditions, hypertension, neurological diseases or diabetes , 4) medications that can interfere with the ANS, including beta-receptor agonists or antagonists, antiarrhythmic agents or antihypertensive drugs, anticholinergic agents or adrenergic alpha-antagonists, tricyclic or serotoninergic antidepressants.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01409512
Start Date
September 1 2011
End Date
September 1 2013
Last Update
August 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zvolon Medical Center
Haifa, Israel, 34987